God, I hate the Watchtower Society!!!! Bunch of creepy hypocrites! Up until now I have relied on others who know about making web pages to archive the information, but now I am downloading my own copies of as much material as possible. They will NEVER retrieve and be able to control the flow of ALL their publications and letters as long as I (and you others, too) have breath in our bodies. The jackasses!
outnfree
JoinedPosts by outnfree
-
185
The Watchtower Society killed my website
by Elsewhere inyou can thank the watchtower society for this.. here is an email from my hosting company:.
unfortunately it appears your site/account was involved in violation of using copyrighted material involved with watch tower bible and tract society of pennsylvania.".
as a result of this abuse and activity, we will be unable to reinstate this account for any reason.. in addition, due to the nature of this abuse and the risk of transferring sensitive or illegal content if we were to provide you your files, we will be unable to provide with backups.. it is unfortunate that this has occurred, and we are aware that more than likely this was not your intent to host, however the fact remains it did exist and complaints were made.
-
-
-
48
Letter to Ritchie's Mom
by jgnat ina young man is on the verge of saying goodbye to his mother.
he's forced in to this position due by a rigid organization that punishes strength, intelligence, and individuality.
i dedicate this thread to all good thoughts about richie rich.
-
-
outnfree
Dear Ritchie's Mom:
I, too, admire your son for his intelligence, his wit, his compassion, and his integrity. You have raised a wonderful human being. Please be proud and never fail to show him that you return to him the great love he holds for you.
Sincerely yours,
Brenda
-
55
XXJW's...Dem's or Rep's??? Why?
by upside/down inwhat do you think xxjw's tend to become politically in the usa?
the phrase from the frying pan into the fire seems appropriate.
i'm not an anarchist...but i refuse to trade religious masters for political ones... but some enjoy exercises in futility...just look at the die hard dubbies.. it seems that the borg mentality tends to produce more dem's (or they just talk louder?
-
-
outnfree
My experience is that XXJWs tend to become Democrats here in the U.S. I think Jourles has something when he mentions that most JWs supported environmental stewardship, and such stewardship is linked more closely with the Democratic party. I also think people who became JWs or were raised JWs are used to expecting something/One greater than themselves to take care of things, tell them the correct "formula for salvation", and to be not only benevolent but benign in their dealings. Democrats often give the impression of being the party with the "formula" for ensuring that the little guy will not be overlooked and that True Justice for ALL (TM) will prevail. Therefore, the fit is more comfortable -- at least initially. And who could argue that universal health care, for example, is not something that all humans deserve?
I think it VERY wise to examine issues for themselves and not just to tout the party line. In Michigan, you can vote for more than one party if you do not declare yourself in a primary race. This is what I myself have done, voting Republican on some issues/positions and Democratic on others. I, too, wish there were actually some viable choices for winners besides Dems or Reps, but, frankly, there are not, and I don't have the energy nor the passion about politics to try to make a third party work.
Someday soon I'll begin putting my $ .02 in about local government.
-
58
I NEED YOUR HELP WITH LAWSUIT AGAINST THE WATCHTOWER
by SHUNNED FATHER ini need your help to continue my lawsuit against the watchtower society and the doctor who the watchtower society arranged for to give my daughter arsenic.
the wts lawyer, hlc members and the doctor deceived bethany and lied to her, convincing her that arsenic would cure her.
bethany was convinced that arsenic could cure her and was curing her.
-
-
outnfree
BTTT
-
18
YOU ALMOST DIED IN 1983....this man saved your life!
by Terry inthe man who saved the world.
posted: december 20, 2005. .
by jim rutz.
-
-
outnfree
My profound thanks to Stanislav Petrov! Without him, I would never have had the joys of becoming a mother. My eldest was born in March 1984, so I was pregnant with her then. In fact, on Sept. 25, 1983 I would have just come off bedrest because we weren't sure the pregnancy was going to be successful.
The world owes him a debt of gratitude of the highest order, doesn't it?
out
-
144
ORANGEFATCAT HAS A BRAIN TUMOR
by orangefatcat inyes, it is so, that i have a brain tumor and i will be going to the hospital in about two hours.
i will ask my son richard to keep all of you posted.
i have all of you in my heart.
-
-
outnfree
Oh, my! When I saw your name on the Vigil thread, I thought you were suffering from some kind of cancer! A brain tumor is so much more scary and immediate! Has your son posted an update? Not sure, so I will be contacting him via e-mail. As you may recall, my daughter Lena (whom you met this past summer at Lawence's) had brain surgery last January. I do hope your results are as successful as hers. You're a lovely person, Terry, and I'm richer for having met you. I will be praying and meditating in your direction as you recover. Love, Brenda
-
31
Just checking in: Life is GREAT and I'm SO HAPPY
by berylblue inas an ex-jw.. for those of you who are wondering if there is life beyond the wtbts -.
yes, there is.. a very fulfilling, exciting, satisfying life.. i am now a store manager candidate for a national pharmacy chain - will have my own store within 6 months - .
my grandson is beautiful and both my children are in constant contact.. i will be getting married to a wonderful man in a few months - and.
-
-
outnfree
I LOVE hearing these stories! Congratulations, berylblue! Guess you're not "blue" anymore, eh?Meanwhile, I'm curious like sally -- what do you do to become a Disgusting Yahoo Troll?
out
-
-
-
outnfree
ps: yes, by all means start training the boy to carry you -- unclebruce
LOL
FE203 -- He sure is a cutie! I so loved it when my children were little! Glad you're enjoying him.
-
8
Anybody study Nostradamus Or His...
by Legolas inprophesies?
i have been looking into them lately especially the third antichrist!
so what do you think about him or his prophesies?
-
-
outnfree
Read him back in the early 80's and then threw out the book when I began seriously studying with the witlesses. Sorry!
-
58
I NEED YOUR HELP WITH LAWSUIT AGAINST THE WATCHTOWER
by SHUNNED FATHER ini need your help to continue my lawsuit against the watchtower society and the doctor who the watchtower society arranged for to give my daughter arsenic.
the wts lawyer, hlc members and the doctor deceived bethany and lied to her, convincing her that arsenic would cure her.
bethany was convinced that arsenic could cure her and was curing her.
-
-
outnfree
In fairness, that article Eduardo linked to is dated November 1998.
Since then, Trisenox (brand name for arsenic trioxide) has been approved for use in treating acute promylecytic leukemia (APL) BUT it has ONLY been approved for treatment of APL.
Cell Therapeutics, Inc. (CTI) Sells TRISENOX(R) to Cephalon, Inc. for $70 Million in Cash and Up to $100 Million in Potential Future Milestone Payments
- CTI Refocuses Infrastructure on Its Late-Stage Pipeline
- XYOTAX(TM) and Pixantrone
- Move Cuts Expenses and Strengthens Balance SheetSEATTLE, June 13 /PRNewswire-FirstCall/ -- CTI Technologies, Inc. (CTIT), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; Nuovo Mercato) announced that it has agreed to sell the TRISENOX brand to Cephalon, Inc. (Nasdaq: CEPH - News). Under the terms of the agreement, Cephalon will pay to CTI and its affiliates an aggregate of approximately $70 million for TRISENOX and certain proteasome assets, subject to a working capital adjustment. In addition, CTI may receive in the future up to an additional $100 million in cash if certain sales and regulatory milestones are achieved.
The agreement is subject to customary closing conditions, including Hart- Scott-Rodino clearance. Under the terms of its existing financing agreement for TRISENOX, CTI is required to use a portion of the proceeds from the sale to repay PharmaBio Development. CTI expects the gross up front proceeds from the transaction, prior to closing costs, will be approximately $30 million after repayment of the PharmaBio agreement. CTI expects the transaction to close during the third quarter.
Under the terms of the agreement, Cephalon will assume control of the worldwide marketing, sales, and development of TRISENOX. Cephalon will offer employment to CTI's U.S.-based commercial employees. The agreement also provides for CTI to transfer to Cephalon sole rights to its current joint proteasome inhibitor research collaboration, which is in preclinical development. Cephalon will assume all costs for advancing the proteasome inhibitor candidate and will pay CTI royalties on future worldwide product sales. CTI and Cephalon have also negotiated a transitional services agreement to support the successful transfer of TRISENOX and the proteasome inhibitor program to Cephalon, during which time Cephalon will reimburse CTI for services related to the transition."TRISENOX is an effective therapy for certain hematologic malignancies and Cephalon has the expertise and resources necessary to maximize its value. This agreement allows the Company to focus its resources on taking XYOTAX through to its NDA filing and advancing pixantrone through its phase III program," stated James A. Bianco, M.D., President and CEO of CTI. "The size of the solid tumor market is more attractive for us and, coupled with the XYOTAX product profile demonstrated in its phase III clinical trials, we believe focusing on bringing XYOTAX to market will have the highest return on investment for our shareholders and is consistent with our long-term strategy in oncology."
TRISENOX (arsenic trioxide), which generated worldwide sales revenues of $26.6 million in 2004, was approved in the United States in 2000 and in Europe in 2002 for the treatment of patients with relapsed or refractory acute promyelocytic leukemia (APL), a life-threatening hematologic cancer. In clinical trials, TRISENOX has been shown to provide high complete response rates (70-75%) and a high molecular remission rate (82%) in patients with relapsed disease, while offering a unique non-chemotherapy side-effect profile. CTI acquired worldwide rights to TRISENOX when it acquired PolaRx in 2000.
As a result of the agreement with Cephalon and an internal reorganization, CTI's headcount will be reduced by approximately 130 in the United States, which is expected to reduce its operating expenses, as the Company focuses its resources and efforts on the development of XYOTAX and pixantrone. CTI expects to pay $1.4 million in the third quarter of 2005 as a result of the workforce reductions. Steve Aselage, Executive Vice President of Global Commercial Operations, will be assisting with the TRISENOX transition before leaving CTI at the end of June.
"We appreciate the significant advancements made in our commercial capabilities under Steve's leadership as well as the efforts of the TRISENOX team," Bianco noted. "We believe the steps announced today place CTI in the financial position to continue the development of our product pipeline and to advance XYOTAX toward commercialization."
About TRISENOX®
TRISENOX® (arsenic trioxide) is marketed by CTI. TRISENOX was approved for marketing in 2000 by the U.S. Food and Drug Administration to treat patients with relapsed or refractory acute promyelocytic leukemia (APL), a rare, life-threatening cancer of the blood. TRISENOX was granted marketing authorization from the European Commission in March 2002. APL, one of eight subtypes of acute myeloid leukemia (AML), represents 10-15 percent of the more than 20,000 patients diagnosed with AML each year. TRISENOX is currently being studied in more than 40 clinical and investigator-sponsored trials in a variety of cancers.
U.S. marketing approval for TRISENOX was granted based on results from a U.S. multicenter study in which 40 relapsed APL patients were treated with TRISENOX 0.15 mg/kg until bone marrow remission or a maximum of 60 days. Thirty-four patients (85 percent) achieved complete remission. When the results for these 40 patients were combined with those for the 12 patients in a pilot trial, an overall response rate of 87 percent was observed.
WARNING: TRISENOX should be administered under the supervision of a physician who is experienced in the management of patients with acute leukemia. Some patients with APL treated with TRISENOX have experienced APL differentiation syndrome -- with symptoms similar to retinoic acid-acute promyelocytic leukemia (RA-APL) syndrome. Arsenic trioxide can cause QT prolongation (which can lead to torsade de pointes) and complete atrioventricular block.
The most common adverse events associated with TRISENOX have been generally manageable, reversible and usually did not require interruption of therapy. These have included hypokalemia, hypermagnesemia, hyperglycemia and thrombocytopenia as reported in 13 percent of the patients (n=40). Abdominal pain, dyspnea, hypoxia, bone pain and neutropenia were reported in 10 percent of these patients, while arthralgia, febrile neutropenia and disseminated intravascular coagulation were reported in eight percent of patients.
http://www.leukemia-web.org/aml-leukemia-news/leukemia-cancer-news-0081.htm (Second article on the cited page.)
Anyway, as rebel8 pointed out, Bethany's diagnosis was AML. And she was a child - 16. Stats on AML treatment responses are generally made for the 18-60 year old and then 60+ year old patients. So even experimental use of Trisenox on a person younger than 18 with AML would have been very risky, one would think.
Here is a wonderful resource page on AML which pretty much explains AML and its treatments and prognoses, and touches on APL treatment as well:
http://www.emedicine.com/MED/topic34.htm
And from that page:
Drug Name Arsenic trioxide (Trisenox) -- Used in patients with relapsed APL. The mechanism of action of Trisenox is not completely understood. Arsenic trioxide causes morphological changes and DNA fragmentation characteristic of apoptosis in NB4 human promyelocytic leukemia cells in vitro. Arsenic trioxide also causes damage or degradation of the fusion protein PML-RAR alpha. Adult Dose Induction: 0.15 mg/kg/d IV until bone marrow remission occurs; maximum induction is 60 doses Consolidation: 0.15 mg/kg/d IV starting 3-6 wk after completion of induction therapy; maximum consolidation is 25 doses over 5 wk Pediatric Dose Not established Contraindications Documented hypersensitivity Interactions Electrolyte abnormalities may occur if used concomitantly with diuretics or amphotericin B; concurrent use with QTc-prolonging agents (type Ia and type II antiarrhythmic agents, cisapride, thioridazine, selected quinolones) may increase risk of potentially fatal arrhythmias Pregnancy D - Unsafe in pregnancy Precautions Correct electrolyte abnormalities prior to treatment and monitor potassium and magnesium levels during therapy; may prolong QT interval; discontinue therapy and hospitalize patient if QTc >500 ms or if syncope or irregular heartbeats develop during therapy; may lead to torsade de pointes or complete AV block (risk factors include congestive heart failure, history of torsade de pointes, preexisting QT interval prolongation, use of potassium-wasting diuretics, conditions that cause hypokalemia or hypomagnesemia) So even if Bethany had the APL form of AML, pediatric use of Trisenox would have been controversial.